Patents/Assignees

Array Biopharma Inc.

25 patents in portfolio

US12465593utility2025
Pharmaceutical Composition
0 cites
US12364684utility2025
Pharmaceutical Composition
0 cites
US12351571utility2025
Substituted Quinoxaline Compounds as Inhibitors of FGFR Tyrosine Kinases
0 cites
US12318367utility2025
Pharmaceutical Composition
0 cites
US12220403utility2025
Pharmaceutical Composition
0 cites
US12187721utility2025
Protein Tyrosine Phosphatase Inhibitors
0 cites
US12180207utility2024
Substituted Pyrazolo[1,5-a]pyridine Compounds as Inhibitors of FGFR Tyrosine Kinases
0 cites
US12171739utility2024
N4-phenyl-quinazoline-4-amine Derivatives and Related Compounds as Erbb Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases
0 cites
US11998545utility2024
Substituted Pyrazolo[1,5-a]pyridine Compounds as RET Kinase Inhibitors
0 cites
US11964988utility2024
Fused Heterocyclic Compounds as RET Kinase Inhibitors
0 cites
US11964989utility2024
Kras G12D Inhibitors
0 cites
US11932633utility2024
Kras G12C Inhibitors
0 cites
US11884664utility2024
Protein Tyrosine Phosphatase Inhibitors
0 cites
US11851434utility2023
Substituted Pyrazolo[1,5-a]pyrazine Compounds as Ret Kinase Inhibitors
0 cites
US11834453utility2023
Substituted Pyrimido[5,4-d]pyrimidines as HER2 Inhibitors
0 cites
US11813246utility2023
Pharmaceutical Composition
0 cites
US11807651utility2023
Process for the Preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
0 cites
US11780835utility2023
Pyrazolo[3,4-b]pyridine Compounds as Inhibitors of TAM and MET Kinases
0 cites
USRE049556reissue2023
Compounds and Compositions as Protein Kinase Inhibitors
0 cites
US11648243utility2023
Substituted Pyrazolo[1,5-a]pyridine Compounds as RET Kinase Inhibitors
0 cites

Page 1 of 2Next →